The Time To Buy Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Is Now – Marketing Sentinel
Home  »  Science   »  The Time To Buy Corbus Pharmaceuticals Holdings In...

The Time To Buy Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Is Now

During the last session, Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)’s traded shares were 2.07 million, with the beta value of the company hitting 2.02. At the end of the trading day, the stock’s price was $0.21, reflecting an intraday loss of -11.36% or -$0.03. The 52-week high for the CRBP share is $2.29, that puts it down -990.48 from that peak though still a striking -9.52% loss since the share price plummeted to a 52-week low of $0.23. The company’s market capitalization is $28.31M, and the average intraday trading volume over the past 10 days was 0.53 million shares, and the average trade volume was 984.88K shares over the past three months.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) trade information

Corbus Pharmaceuticals Holdings Inc. (CRBP) registered a -11.36% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -11.36% in intraday trading to $0.21 this Thursday, 05/12/22, hitting a weekly high. The stock’s 5-day price performance is -33.35%, and it has moved by -48.50% in 30 days. Based on these gigs, the overall price performance for the year is -84.89%. The short interest in Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) is 6.4 million shares and it means that shorts have 6.61 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Corbus Pharmaceuticals Holdings Inc. (CRBP) estimates and forecasts

Statistics show that Corbus Pharmaceuticals Holdings Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Corbus Pharmaceuticals Holdings Inc. (CRBP) shares have gone down -79.00% during the last six months, with a year-to-date growth rate more than the industry average at 21.62% against 9.70. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -10.00% this quarter and then jump 21.40% in the quarter after that. In the rating firms’ projections, revenue will decrease -71.60% compared to the previous financial year.

Revenue for the current quarter is expected to be $230k as predicted by 3 analyst(s). As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $658k and $648k respectively.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 5.30%. While earnings are projected to return 73.90% in 2022.

CRBP Dividends

Corbus Pharmaceuticals Holdings Inc. is due to release its next quarterly earnings between March 14 and March 18. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)’s Major holders

Corbus Pharmaceuticals Holdings Inc. insiders own 0.42% of total outstanding shares while institutional holders control 36.47%, with the float percentage being 36.62%. ETF Managers Group, LLC is the largest shareholder of the company, while 103 institutions own stock in it. As of Sep 29, 2021, the company held over 14.1 million shares (or 11.26% of all shares), a total value of $14.38 million in shares.

The next largest institutional holding, with 5.47 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 4.37% of outstanding shares. At the market price on Sep 29, 2021, these shares were valued at $5.58 million.

Also, the Mutual Funds coming in first place with the largest holdings of Corbus Pharmaceuticals Holdings Inc. (CRBP) shares are ETF Managers Tr-EFTMG Alternative Harvest ETF and Vanguard Total Stock Market Index Fund. Data provided on Sep 29, 2021 indicates that ETF Managers Tr-EFTMG Alternative Harvest ETF owns about 14.1 million shares. This amounts to just over 11.26 percent of the company’s overall shares, with a $14.38 million market value. The same data shows that the other fund manager holds slightly less at 3.52 million, or about 2.81% of the stock, which is worth about $3.59 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts